Emerging oligonucleotide therapeutics for rare neuromuscular diseases
Research and drug development concerning rare diseases are at the cutting edge of scientific technology. To date, over 7,000 rare diseases have been identified. Despite their individual rarity, 1 in 10 individuals worldwide is affected by a rare condition. For the majority of these diseases, there i...
Những tác giả chính: | Aoki, Y, Wood, MJA |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
IOS Press
2021
|
Những quyển sách tương tự
-
Oligonucleotide-based therapies for neuromuscular disease
Bằng: Douglas, A, et al.
Được phát hành: (2015) -
Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases
Bằng: Tsoumpra, MK, et al.
Được phát hành: (2019) -
Advances in oligonucleotide drug delivery
Bằng: Roberts, TC, et al.
Được phát hành: (2020) -
Recent advances in antisense oligonucleotide therapy in genetic neuromuscular diseases
Bằng: Ashok Verma
Được phát hành: (2018-01-01) -
Cell-penetrating peptide conjugates of steric blocking oligonucleotides as therapeutics for neuromuscular diseases from a historical perspective to current prospects of treatment
Bằng: Gait, M, et al.
Được phát hành: (2018)